nad has been researched along with Leukemia P388 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Betts, CR; Cooney, DA; Gebeyehu, G; Jayaram, HN; Johns, DG; Kelley, JA; Marquez, VE | 1 |
| Cooney, DA; Gebeyehu, G; Jayaram, HN; Johns, DG; Kelley, JA; Marquez, VE | 1 |
| Ahluwalia, GS; Cooney, DA; Dion, RL; Gebeyehu, G; Jayaram, HN; Johns, DG; Kelley, JA; Marquez, VE; Robins, RK | 1 |
| Auer, B; Föger, B; Geisen, F; Hoppichler, F; Konwalinka, G; Lechleitner, M; Patsch, JR; Schirmer, M; Zilian, U | 1 |
| Cheung, A; Huang, S; Lautar, S; Li, JH; Ramsey, C; Zhang, J | 1 |
| Ahluwalia, GS; Cooney, DA; Dion, RL; Gebeyehu, G; Jayaram, HN; Johns, DG; Kelley, JA; Marquez, VE; Van Cott, A; Wilson, YA | 1 |
| Cochrane, CG; Hinshaw, DB; Hyslop, PA; Schraufstatter, IU; Spragg, RG | 2 |
8 other study(ies) available for nad and Leukemia P388
| Article | Year |
|---|---|
The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Topics: Adenosine; Animals; Antineoplastic Agents; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Leukemia P388; Male; Mice; NAD; Ribavirin; Ribonucleosides | 1982 |
Synthesis of thiazole-4-carboxamide adenine dinucleotide. A powerful inhibitor of IMP dehydrogenase.
Topics: Adenine Nucleotides; Animals; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Leukemia P388; Mice; NAD | 1983 |
Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Topics: Animals; Gas Chromatography-Mass Spectrometry; IMP Dehydrogenase; Ketone Oxidoreductases; Leukemia P388; Leukemia, Experimental; Mice; NAD; Organoselenium Compounds; Ribavirin; Ribonucleosides; Selenium | 1983 |
The immunosuppressive substance 2-chloro-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (P388 cells).
Topics: Acetylation; Aminophylline; Animals; Benzamides; Cell Line; Cholesterol; Cholesterol Esters; Cladribine; Deoxycytidine Kinase; Hydroxymethylglutaryl CoA Reductases; Leukemia P388; Lipoproteins; Lipoproteins, LDL; Macrophages; Mice; NAD; Oleic Acid; Oleic Acids; Triglycerides | 1994 |
GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
Topics: ADP Ribose Transferases; Animals; Benzopyrans; Cell Survival; DNA Damage; DNA Repair; Enzyme Inhibitors; Hydrogen Peroxide; Isoquinolines; Kinetics; Leukemia P388; Methylnitronitrosoguanidine; Mice; NAD; Plasmids; Poly(ADP-ribose) Polymerase Inhibitors; Transfection; Tumor Cells, Cultured | 2000 |
Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.
Topics: Animals; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Leukemia P388; Mice; NAD; Organoselenium Compounds; Ribavirin; Ribonucleosides; Selenium | 1985 |
Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.
Topics: Adenosine Triphosphate; Animals; Culture Media; DNA; DNA Repair; DNA, Single-Stranded; Enzyme Activation; Hydrogen Peroxide; Lead; Leukemia P388; Macrophages; Mice; NAD; Niacinamide; Poly(ADP-ribose) Polymerases; Time Factors | 1986 |
Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells.
Topics: Animals; Glutathione; Glutathione Disulfide; Humans; Hydrogen Peroxide; Leukemia P388; Leukemia, Experimental; NAD; NADP; Oxidation-Reduction; Pentose Phosphate Pathway | 1985 |